Doorgaan naar hoofdnavigatie Doorgaan naar zoeken Ga verder naar hoofdinhoud

Goals, Expectations, and the Definition of Success for Neuromodulation for Pain According to Representatives of Neuromodulation Device Manufacturers

Maarten Moens, William Alliet, Maxime Billot, Ann De Smedt, Panagiotis Flamée, Domien Vanhonacker, Manuel Roulaud, Philippe Rigoard, Lisa Goudman

Onderzoeksoutput: Articlepeer review

Samenvatting

Representatives of neuromodulation device manufacturers are expected to facilitate the relationship between patients and healthcare providers. Nevertheless, the goals, expectations, and definition of success for neuromodulation for pain have not yet been explored. Representatives present at the 2nd Joint Congress of the INS European Chapters in September 2021 completed a survey to ascertain their opinions about the goals to achieve with neuromodulation, the factors that they expect to change, and their definition of success for neuromodulation. In total, 39 representatives completed the survey. To provide excellent service for patients (22.4%), to become a trusted partner for physicians (21.5%), and to provide excellent service for physicians (20.7%) were the highest ranked goals. The most frequently reported factors that were expected to change were pain intensity (23.1%), patient satisfaction (19.7%), mobility/functioning (14.5%), and capacity to return to work (13.7%). Within the definitions of success, increased quality of life of the patient was stated in 21% of the definitions, closely followed by pain control (19.3%) and happiness/patient satisfaction (15.8%). The goals of representatives of neuromodulation device manufacturers seem to focus on ensuring a good relationship with physicians on the one hand and providing good service towards patients on the other hand, whereby pain control, quality of life, and patient satisfaction seem to be important for company representatives.

Originele taal-2English
Artikelnummer1457
Pagina's (van-tot)1-11
Aantal pagina's11
TijdschriftJournal of Personalized Medicine
Volume12
Nummer van het tijdschrift9
DOI's
StatusPublished - 6 sep. 2022

Bibliografische nota

Funding Information:
Lisa Goudman is a postdoctoral research fellow funded by the Research Foundation Flanders (FWO), Belgium (project number 12ZF622N). Philippe Rigoard reports grants and personal fees from Medtronic, Abbott, and Boston Scientific outside the submitted work. Maarten Moens has received speaker fees from Medtronic and Nevro. STIMULUS received research grants from Medtronic. There are no other conflicts of interests to declare.

Publisher Copyright:
© 2022 by the authors.

Copyright:
Copyright 2022 Elsevier B.V., All rights reserved.

Vingerafdruk

Duik in de onderzoeksthema's van 'Goals, Expectations, and the Definition of Success for Neuromodulation for Pain According to Representatives of Neuromodulation Device Manufacturers'. Samen vormen ze een unieke vingerafdruk.

Citeer dit